15–17 March 2019
Los Angeles Convention Center in LA
The 16th Annual World Congress of SBMT brought together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies (operative and non-operative). The conference took place at the Los Angeles Convention Center.
The goal of the conference was to create a critical mass by introducing synergy amongst inter-disciplinary researchers to further understand the brain function and nervous system. It also served as a platform from which to develop interactions between many of the stakeholders who had extensive collaborations at national and international levels.
The conference provided the opportunity to be at the forefront of brain sciences, therapeutics in general and neural stem cells interventions in particular. It served as a strong platform for industry and biotech companies to interact with academia in frontiers of science in this field for translational initiatives involving diverse patient’s interest groups.
16th Annual Congress of Society for Brain Mapping promotional video – 2019 from Brain Mapping Foundation on Vimeo.
Topics & Speakers
Moderator: Mike Piscotty, ALS Cure
Biomarkers to aid diagnosis and monitor drug efficacy in clinical trials for ALS
Robert Bowser, Ph.D. The Barrow Neurological Institute
Biomarkers for CNS injury and disease
Kendall Van Keuren-Jensen , Ph.D. TGen
A data-driven approach links microglia to pathology and prognosis in ALS
Johnathan Cooper-Knock Ph.D. University of Sheffield, UK
Allosteric assembly machine modulators for ALS therapeutics
Vishwanath R Lingappa, M.D., Ph.D. Prosetta Sciences
Financing ALS biomarker discovery
Natalie Fernandez, 2019 MBA Candidate, The Martha Olson-Fernandez Foundation
The interdisciplinary nature of the SBMT conference allowed the ALS biomarker panel members to learn and collaborate with fellow industry members. The biomarker research topics were promising. Stay tuned for research article postings on the studies discussed.
Director Bobak Kalhor interviewed each of the panelist for an ALS media project. Bobak is director of “A Dying King- The Shah of Iran.” He recently lost his mother to ALS.
